ARCHIVES

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Concepts For Three New RFA Programs

July 6, 1984

NCI Should Toughen Deadlines, Quality, in RAID program, Advisory Committee Says.

October 6, 2006

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011

McKenna Sees Budget Cuts as Threat to Year 2000 Goals Urges Stepped Up Efforts Against Tobacco Industry

April 5, 1985

Rare Lung Disease Raises Risk Of Meningiomas

October 26, 2001

DePinho Bets MD Anderson Credibility On His Cancer “Moon Shot” Program

September 7, 2012